Dr Daniel L West, MD | |
1212 E Sherman Blvd, Muskegon, MI 49444-1879 | |
(231) 672-3500 | |
(231) 672-6199 |
Full Name | Dr Daniel L West |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 40 Years |
Location | 1212 E Sherman Blvd, Muskegon, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154315505 | NPI | - | NPPES |
1990413 | Medicaid | MI |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Health Hackley Campus | Muskegon, MI | Hospital |
Mercy Health Lakeshore Campus | Shelby, MI | Hospital |
North Ottawa Community Health System | Grand haven, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Health Westshore Cardiology Services | 5991932360 | 29 |
News Archive
Scientists have long puzzled over cholesterol. It's biologically necessary; it's observably harmful - and nobody knows what it's doing where it's most abundant in cells: in the cell membrane.
The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).
Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The study by researchers from Sweden also found that RA patients who smoked in the past did not experience a lower response to these therapies. Results of the 10-year study appear in the January 2011 issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights.
› Verified 8 days ago
Entity Name | Mercy Health Westshore Cardiology Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336573393 PECOS PAC ID: 5991932360 Enrollment ID: O20131210000146 |
News Archive
Scientists have long puzzled over cholesterol. It's biologically necessary; it's observably harmful - and nobody knows what it's doing where it's most abundant in cells: in the cell membrane.
The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).
Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The study by researchers from Sweden also found that RA patients who smoked in the past did not experience a lower response to these therapies. Results of the 10-year study appear in the January 2011 issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel L West, MD Po Box 1847, Muskegon, MI 49443-1847 Ph: (231) 727-4444 | Dr Daniel L West, MD 1212 E Sherman Blvd, Muskegon, MI 49444-1879 Ph: (231) 672-3500 |
News Archive
Scientists have long puzzled over cholesterol. It's biologically necessary; it's observably harmful - and nobody knows what it's doing where it's most abundant in cells: in the cell membrane.
The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).
Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The study by researchers from Sweden also found that RA patients who smoked in the past did not experience a lower response to these therapies. Results of the 10-year study appear in the January 2011 issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights.
› Verified 8 days ago
Edward Tanudjaja, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 | |
Dr. Karen A Thornburg, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Baker St Fl 3, Muskegon, MI 49444 Phone: 231-737-1335 Fax: 231-737-0534 | |
Mathew J Brakora, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883 | |
Abbaseh Saedi, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1150 E Sherman Blvd Ste 1175, Muskegon, MI 49444 Phone: 231-672-6740 | |
Dr. Jon Hinderer, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 684 Harvey St, Muskegon, MI 49442 Phone: 231-777-5906 Fax: 231-773-8904 | |
Krishna Chaitanya Meka, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2009 Holton Rd, Muskegon, MI 49445 Phone: 616-935-3479 | |
Dr. Nino Pio Soave, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2009 Holton Rd, Muskegon, MI 49445 Phone: 616-267-7414 |